NCT05671770View on ClinicalTrials.gov

Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

CompletedOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

December 14, 2023

Study Completion Date

December 14, 2023

Conditions

Fabry Disease

Trial Locations (1)

11111

Cleveland Clinic AbuDhabi, Abu Dhabi

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY